PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 60 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 20.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $179,000 | -30.1% | 162,500 | -12.9% | 0.00% | 0.0% |
| Q2 2020 | $256,000 | +32.6% | 186,600 | +10.5% | 0.00% | 0.0% |
| Q1 2020 | $193,000 | -44.2% | 168,900 | +11.3% | 0.00% | 0.0% |
| Q4 2019 | $346,000 | +529.1% | 151,700 | +133.7% | 0.00% | – |
| Q3 2019 | $55,000 | +17.0% | 64,900 | +34.9% | 0.00% | – |
| Q2 2019 | $47,000 | +95.8% | 48,100 | +154.5% | 0.00% | – |
| Q1 2019 | $24,000 | -80.0% | 18,900 | -48.8% | 0.00% | – |
| Q4 2018 | $120,000 | +30.4% | 36,900 | -2.9% | 0.00% | – |
| Q3 2018 | $92,000 | -34.8% | 38,000 | -24.6% | 0.00% | – |
| Q2 2018 | $141,000 | – | 50,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 5,556,778 | $4,695,000 | 0.39% |
| GREAT POINT PARTNERS LLC | 3,500,000 | $2,958,000 | 0.27% |
| HARBOURVEST PARTNERS LLC | 440,627 | $372,000 | 0.16% |
| VHCP Management III, LLC | 221,267 | $187,000 | 0.12% |
| VHCP Management II, LLC | 130,733 | $110,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 184,955 | $156,000 | 0.02% |
| Bain Capital Public Equity Management II, LLC | 202,050 | $171,000 | 0.02% |
| Kazazian Asset Management, LLC | 12,769 | $11,000 | 0.02% |
| Rock Springs Capital Management LP | 400,000 | $338,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 138,056 | $117,000 | 0.01% |